ANDREA
LOPEZ LOPEZ
Investigadora no período 2022-2024
Publicacións (27) Publicacións de ANDREA LOPEZ LOPEZ
2023
-
Impact of Hyperkalemia in Heart Failure and Reduced Ejection Fraction: A Retrospective Study
Journal of Clinical Medicine, Vol. 12, Núm. 10
-
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
Antioxidants, Vol. 12, Núm. 7
2022
-
Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures
Antioxidants, Vol. 11, Núm. 2
-
Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy
Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273
-
Cardiac amyloidosis: Description of a series of 143 cases
Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213
-
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428
2021
2020
-
Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
Frontiers in Neuroanatomy, Vol. 14
-
Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease
British Journal of Pharmacology, Vol. 177, Núm. 24, pp. 5622-5641
2019
-
Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study
Journal of Gastroenterology and Hepatology (Australia), Vol. 34, Núm. 1, pp. 277-283
2018
-
Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis
Journal of Clinical Gastroenterology, Vol. 52, Núm. 8, pp. e63-e72
2017
-
Percutaneous Coronary Intervention and Cardiac Surgery in Cancer Patients
Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions (Elsevier Inc.), pp. 357-362
2016
-
El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año
Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 11-18
-
RETRACTED ARTICLE: Long-term mortality prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter
Clinical Research in Cardiology, Vol. 105, Núm. 4, pp. 377
2015
-
Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 15, Núm. 1
-
Evaluation of SAMe-TT<inf>2</inf>R<inf>2</inf> risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists
Europace, Vol. 17, Núm. 5, pp. 711-717
-
Impacto de la fibrilación ventricular que complica el curso de un síndrome coronario agudo en la incidencia a largo plazo de muerte súbita cardiaca
Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 878-884
-
Long-term outcome prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter
International Journal of Cardiology, Vol. 199, pp. 426-428
-
Pronóstico a largo plazo de pacientes con infarto agudo de miocardio sin elevación del segmento ST y arterias coronarias sin estenosis significativa
Revista Espanola de Cardiologia, Vol. 68, Núm. 9, pp. 777-784